Grail names new CEO as Bob Ragusa retires
Jared Whitlock / endpoints - Grail on Thursday announced that its CEO, Bob Ragusa, will retire and is handing the reins to its current president Josh Ofman. The cancer screening company said the move was the culmination of long-term succession ...
AI Summary: Grail announced a leadership transition as long‑time chief executive Bob Ragusa retires and hands operational control to current president Josh Ofman. The move marks a new chapter for the cancer‑screening company as stakeholders watch for strategic shifts and commentary about the company’s unusual corporate journey and future direction.
Related Stories
Ultra‑sensitive ctDNA blood test could personalize breast cancer care for older women / 3 months
FDA clears blood test to guide breast cancer therapy choices / 2 months
Liquid biopsy may speed childhood Burkitt lymphoma diagnosis in Africa / 3 months
Cancer Grand Challenges awards five teams bold funding for cancer research / 4 months
Two high‑dose radiotherapy sessions safely treat localized prostate cancer / 7 wks
Grail’s Galleri blood test misses UK study goal; investor jitters / 4 months
Bristol Myers and Hengrui strike up to $15.2B global oncology pact / 1 month
StackHealth RSS
You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Trump Administration, Hospital Operations, Food Safety, Pharmaceuticals and look for the RSS link.
StackHealth Time Machine